| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/03/1999 | CN1041920C Glycerin derivative and its pharmacological use |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866689 Monoclonal antibodies to GP130 protein |
| 02/02/1999 | US5866617 Aqueous solution for administration to patients also receiving cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866616 3,3-(disubstituted) cyclohexan-1-ol monomers and related compounds |
| 02/02/1999 | US5866615 Lyophilized formulation with anticancer agents; reduced side effects, increased activity |
| 02/02/1999 | US5866612 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase |
| 02/02/1999 | US5866611 Phenoxypropylamine inhibitors of squalene synthese, useful in treating diseases in which a lowering of cholesterol is desirable. |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866587 Hydroxamide derivatives of fused piperidine derivatives |
| 02/02/1999 | US5866577 Aromatic amidine derivatives and salts thereof |
| 02/02/1999 | US5866571 Treatment of inflammations, thromboembolic diseases and cardiovascular diseases. |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866559 Hormone replacement therapy; endometrioses |
| 02/02/1999 | US5866557 Use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 02/02/1999 | US5866556 Pyridinylbisphosphonates for use as a therapeutical agent |
| 02/02/1999 | US5866540 Cyclic adhesion inhibitors |
| 02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866364 Recombinant bone morphogenetic protein heterodimers |
| 02/02/1999 | US5866169 Lyophilized formulation with cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866168 Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | US5866119 Hybridization; complexing |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/02/1999 | CA1340374C Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
| 02/02/1999 | CA1340363C Mutant acidic fibroblast growth factor |
| 02/01/1999 | CA2238672A1 Seca |
| 01/30/1999 | CA2244438A1 New benzimidazole, benzoxazole and benzothiazole derivatives, their preparation process and the pharmaceutical compositions containing them |
| 01/30/1999 | CA2244435A1 New heterocyclic compounds, their preparation process and the pharmaceutical compounds containing them |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004266A2 Interactions of atm, atr or dna-pk with p53 |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999003992A1 Trail receptor |
| 01/28/1999 | WO1999003990A1 64 human secreted proteins |
| 01/28/1999 | WO1999003989A1 Human atp-binding cassette transport protein |
| 01/28/1999 | WO1999003982A1 Interleukin-20 |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003880A1 Nociceptin analogues |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003876A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | WO1999003870A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 01/28/1999 | WO1999003855A1 Piperazine derivatives |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003837A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 01/28/1999 | WO1999003831A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003823A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | WO1999003822A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | WO1999003817A2 Aliphatic propargylamines as cellular rescue agents |
| 01/28/1999 | WO1999003505A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 01/28/1999 | WO1999003494A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase |
| 01/28/1999 | WO1999003486A1 Antacid and papain combination |
| 01/28/1999 | WO1999003484A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | WO1999003476A1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 01/28/1999 | WO1999003460A1 Amino acid derivatives useful to treat stroke |
| 01/28/1999 | WO1999003365A1 Nutritional composition containing methionine |
| 01/28/1999 | WO1999003364A1 Nutritional composition for subjects under stress |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | WO1998046589A3 Indazole amide compounds as serotoninergic agents |
| 01/28/1999 | WO1998046576A3 Halo-alkoxycarbonyl prodrugs |
| 01/28/1999 | WO1998040056A3 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/28/1999 | WO1998027932A3 Cerebellum and embryo specific protein |
| 01/28/1999 | DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2297413A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | CA2296815A1 64 human secreted proteins |
| 01/28/1999 | CA2296762A1 Interleukin-20 |
| 01/28/1999 | CA2296700A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | CA2296687A1 Piperazine derivatives |
| 01/28/1999 | CA2296540A1 Nutritional composition for subjects under stress |
| 01/28/1999 | CA2296508A1 Structure of the ankyrin binding domain of a alpha-na,k-atpase |
| 01/28/1999 | CA2296498A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
| 01/28/1999 | CA2296416A1 Assays therapeutic methods and means |
| 01/28/1999 | CA2296310A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/28/1999 | CA2295021A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 01/28/1999 | CA2294934A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | CA2294772A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | CA2286357A1 Antacid and papain combination |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892804A1 Isoxazolidine derivatives |
| 01/27/1999 | EP0892797A1 Inhibitors of farnesyl protein transferase |
| 01/27/1999 | EP0892796A1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 01/27/1999 | EP0892795A1 Piperidinylpyramidine derivatives |